Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 10;14(8):109.
doi: 10.1007/s11306-018-1404-2.

A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer

Nguyen Phuoc Long  1 , Sang Jun Yoon  1 , Nguyen Hoang Anh  1 , Tran Diem Nghi  2 , Dong Kyu Lim  1 , Yu Jin Hong  1 , Soon-Sun Hong  3 , Sung Won Kwon  4
Affiliations

A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer

Nguyen Phuoc Long et al. Metabolomics. .

Abstract

Introduction: Metabolomics is an emerging approach for early detection of cancer. Along with the development of metabolomics, high-throughput technologies and statistical learning, the integration of multiple biomarkers has significantly improved clinical diagnosis and management for patients.

Objectives: In this study, we conducted a systematic review to examine recent advancements in the oncometabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.

Methods: PubMed, Scopus, and Web of Science were searched for relevant studies published before September 2017. We examined the study designs, the metabolomics approaches, and the reporting methodological quality following PRISMA statement. RESULTS AND CONCLUSION: The included 25 studies primarily focused on the identification rather than the validation of predictive capacity of potential biomarkers. The sample size ranged from 10 to 8760. External validation of the biomarker panels was observed in nine studies. The diagnostic area under the curve ranged from 0.68 to 1.00 (sensitivity: 0.43-1.00, specificity: 0.73-1.00). The effects of patients' bio-parameters on metabolome alterations in a context-dependent manner have not been thoroughly elucidated. The most reported candidates were glutamic acid and histidine in seven studies, and glutamine and isoleucine in five studies, leading to the predominant enrichment of amino acid-related pathways. Notably, 46 metabolites were estimated in at least two studies. Specific challenges and potential pitfalls to provide better insights into future research directions were thoroughly discussed. Our investigation suggests that metabolomics is a robust approach that will improve the diagnostic assessment of pancreatic cancer. Further studies are warranted to validate their validity in multi-clinical settings.

Keywords: Diagnostic biomarkers; Metabolomics; Pancreatic cancer; Systematic review.

PubMed Disclaimer

References

    1. Nat Protoc. 2011 Jun 30;6(7):1060-83 - PubMed
    1. J Proteome Res. 2012 Feb 3;11(2):1274-83 - PubMed
    1. Anal Chem. 2017 Nov 21;89(22):12360-12368 - PubMed
    1. Curr Opin Clin Nutr Metab Care. 2018 Jan;21(1):64-70 - PubMed
    1. Mass Spectrom Rev. 2018 Jul;37(4):513-532 - PubMed

Publication types

Substances

LinkOut - more resources